Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 May;54(5):398–403. doi: 10.1136/ard.54.5.398

Innervation of the synovium.

P I Mapp 1
PMCID: PMC1005604  PMID: 7540827

Full text

PDF
398

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A human C-type virus. Nature. 1971 Jul 9;232(5306):87–87. doi: 10.1038/232087b0. [DOI] [PubMed] [Google Scholar]
  2. Beresford I. J., Birch P. J., Hagan R. M., Ireland S. J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol. 1991 Oct;104(2):292–293. doi: 10.1111/j.1476-5381.1991.tb12423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Corbally N., Powell D., Tipton K. F. The binding of endogenous and exogenous substance-P in human plasma. Biochem Pharmacol. 1990 Apr 1;39(7):1161–1166. doi: 10.1016/0006-2952(90)90257-l. [DOI] [PubMed] [Google Scholar]
  4. Devault A., Lazure C., Nault C., Le Moual H., Seidah N. G., Chrétien M., Kahn P., Powell J., Mallet J., Beaumont A. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 1987 May;6(5):1317–1322. doi: 10.1002/j.1460-2075.1987.tb02370.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Djokic T. D., Nadel J. A., Dusser D. J., Sekizawa K., Graf P. D., Borson D. B. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi. J Pharmacol Exp Ther. 1989 Jan;248(1):7–11. [PubMed] [Google Scholar]
  6. Donaldson L. F., Harmar A. J., McQueen D. S., Seckl J. R. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Brain Res Mol Brain Res. 1992 Nov;16(1-2):143–149. doi: 10.1016/0169-328x(92)90204-o. [DOI] [PubMed] [Google Scholar]
  7. Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992 Aug;49(3):693–698. doi: 10.1016/0306-4522(92)90237-v. [DOI] [PubMed] [Google Scholar]
  8. Fausto N. What's in a Name? The American Society for Investigative Pathology. Am J Pathol. 1993 Jan;142(1):1–1. [PMC free article] [PubMed] [Google Scholar]
  9. Foreman J. C. Peptides and neurogenic inflammation. Br Med Bull. 1987 Apr;43(2):386–400. doi: 10.1093/oxfordjournals.bmb.a072189. [DOI] [PubMed] [Google Scholar]
  10. Fujii T., Murai M., Morimoto H., Maeda Y., Yamaoka M., Hagiwara D., Miyake H., Ikari N., Matsuo M. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888. Br J Pharmacol. 1992 Nov;107(3):785–789. doi: 10.1111/j.1476-5381.1992.tb14524.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gitter B. D., Waters D. C., Bruns R. F., Mason N. R., Nixon J. A., Howbert J. J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol. 1991 May 17;197(2-3):237–238. doi: 10.1016/0014-2999(91)90532-u. [DOI] [PubMed] [Google Scholar]
  12. Grönblad M., Konttinen Y. T., Korkala O., Liesi P., Hukkanen M., Polak J. M. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1988 Dec;15(12):1807–1810. [PubMed] [Google Scholar]
  13. Hartung H. P., Toyka K. V. Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol. 1983 May 6;89(3-4):301–305. doi: 10.1016/0014-2999(83)90511-3. [DOI] [PubMed] [Google Scholar]
  14. Hartung H. P., Wolters K., Toyka K. V. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol. 1986 May 15;136(10):3856–3863. [PubMed] [Google Scholar]
  15. Helke C. J., Krause J. E., Mantyh P. W., Couture R., Bannon M. J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 1990 Apr 1;4(6):1606–1615. [PubMed] [Google Scholar]
  16. Iwamoto I., Ueki I. F., Borson D. B., Nadel J. A. Neutral endopeptidase modulates tachykinin-induced increase in vascular permeability in guinea pig skin. Int Arch Allergy Appl Immunol. 1989;88(3):288–293. doi: 10.1159/000234808. [DOI] [PubMed] [Google Scholar]
  17. Joyce T. J., Yood R. A., Carraway R. E. Quantitation of substance-P and its metabolites in plasma and synovial fluid from patients with arthritis. J Clin Endocrinol Metab. 1993 Sep;77(3):632–637. doi: 10.1210/jcem.77.3.7690359. [DOI] [PubMed] [Google Scholar]
  18. Katayama M., Nadel J. A., Bunnett N. W., Di Maria G. U., Haxhiu M., Borson D. B. Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides. 1991 May-Jun;12(3):563–567. doi: 10.1016/0196-9781(91)90102-u. [DOI] [PubMed] [Google Scholar]
  19. Kerr M. A., Kenny A. J. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J. 1974 Mar;137(3):477–488. doi: 10.1042/bj1370477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kimball E. S., Persico F. J., Vaught J. L. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease. J Immunol. 1988 Nov 15;141(10):3564–3569. [PubMed] [Google Scholar]
  21. Konttinen Y. T., Kemppinen P., Segerberg M., Hukkanen M., Rees R., Santavirta S., Sorsa T., Pertovaara A., Polak J. M. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994 Jul;37(7):965–982. doi: 10.1002/art.1780370701. [DOI] [PubMed] [Google Scholar]
  22. Konttinen Y. T., Rees R., Hukkanen M., Grönblad M., Tolvanen E., Gibson S. J., Polak J. M., Brewerton D. A. Nerves in inflammatory synovium: immunohistochemical observations on the adjuvant arthritis rat model. J Rheumatol. 1990 Dec;17(12):1586–1591. [PubMed] [Google Scholar]
  23. Lam F. Y., Ferrell W. R. Capsaicin suppresses substance P-induced joint inflammation in the rat. Neurosci Lett. 1989 Oct 23;105(1-2):155–158. doi: 10.1016/0304-3940(89)90028-1. [DOI] [PubMed] [Google Scholar]
  24. Lam F. Y., Ferrell W. R. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis. 1989 Nov;48(11):928–932. doi: 10.1136/ard.48.11.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Letarte M., Vera S., Tran R., Addis J. B., Onizuka R. J., Quackenbush E. J., Jongeneel C. V., McInnes R. R. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med. 1988 Oct 1;168(4):1247–1253. doi: 10.1084/jem.168.4.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levine J. D., Clark R., Devor M., Helms C., Moskowitz M. A., Basbaum A. I. Intraneuronal substance P contributes to the severity of experimental arthritis. Science. 1984 Nov 2;226(4674):547–549. doi: 10.1126/science.6208609. [DOI] [PubMed] [Google Scholar]
  27. Look A. T., Ashmun R. A., Shapiro L. H., Peiper S. C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest. 1989 Apr;83(4):1299–1307. doi: 10.1172/JCI114015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lotz M., Carson D. A., Vaughan J. H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987 Feb 20;235(4791):893–895. doi: 10.1126/science.2433770. [DOI] [PubMed] [Google Scholar]
  29. Mapp P. I., Kidd B. L., Gibson S. J., Terry J. M., Revell P. A., Ibrahim N. B., Blake D. R., Polak J. M. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience. 1990;37(1):143–153. doi: 10.1016/0306-4522(90)90199-e. [DOI] [PubMed] [Google Scholar]
  30. Mapp P. I., Walsh D. A., Garrett N. E., Kidd B. L., Cruwys S. C., Polak J. M., Blake D. R. Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis. 1994 Apr;53(4):240–246. doi: 10.1136/ard.53.4.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mapp P. I., Walsh D. A., Kidd B. L., Cruwys S. C., Polak J. M., Blake D. R. Localization of the enzyme neutral endopeptidase to the human synovium. J Rheumatol. 1992 Dec;19(12):1838–1844. [PubMed] [Google Scholar]
  32. Martin M. F., Surrall K. E., McKenna F., Dixon J. S., Bird H. A., Wright V. Captopril: a new treatment for rheumatoid arthritis? Lancet. 1984 Jun 16;1(8390):1325–1328. doi: 10.1016/s0140-6736(84)91821-x. [DOI] [PubMed] [Google Scholar]
  33. Mazurek N., Pecht I., Teichberg V. I., Blumberg S. The role of the N-terminal tetrapeptide in the histamine releasing action of substance P. Neuropharmacology. 1981 Nov;20(11):1025–1027. doi: 10.1016/0028-3908(81)90091-5. [DOI] [PubMed] [Google Scholar]
  34. Nadel J. A., Borson D. B. Modulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S33–S36. doi: 10.1164/ajrccm/143.3_Pt_2.S33. [DOI] [PubMed] [Google Scholar]
  35. Pereira da Silva J. A., Carmo-Fonseca M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol. 1990 Dec;17(12):1592–1599. [PubMed] [Google Scholar]
  36. Perianin A., Snyderman R., Malfroy B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun. 1989 Jun 15;161(2):520–524. doi: 10.1016/0006-291x(89)92630-2. [DOI] [PubMed] [Google Scholar]
  37. Petitet F., Saffroy M., Torrens Y., Lavielle S., Chassaing G., Loeuillet D., Glowinski J., Beaujouan J. C. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides. 1992 Mar-Apr;13(2):383–388. doi: 10.1016/0196-9781(92)90125-m. [DOI] [PubMed] [Google Scholar]
  38. Precursors of ribosomal RNA. Nature. 1971 Jul 9;232(5306):86–86. doi: 10.1038/232086a0. [DOI] [PubMed] [Google Scholar]
  39. Rees D. D., Palmer R. M., Hodson H. F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989 Feb;96(2):418–424. doi: 10.1111/j.1476-5381.1989.tb11833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Regoli D., Nantel F. Pharmacology of neurokinin receptors. Biopolymers. 1991 May;31(6):777–783. doi: 10.1002/bip.360310623. [DOI] [PubMed] [Google Scholar]
  41. Scott D. T., Lam F. Y., Ferrell W. R. Acute inflammation enhances substance P-induced plasma protein extravasation in the rat knee joint. Regul Pept. 1992 Jun 11;39(2-3):227–235. doi: 10.1016/0167-0115(92)90543-4. [DOI] [PubMed] [Google Scholar]
  42. Skidgel R. A., Engelbrecht S., Johnson A. R., Erdös E. G. Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides. 1984 Jul-Aug;5(4):769–776. doi: 10.1016/0196-9781(84)90020-2. [DOI] [PubMed] [Google Scholar]
  43. Smith G. D., Harmar A. J., McQueen D. S., Seckl J. R. Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat. Neurosci Lett. 1992 Mar 30;137(2):257–260. doi: 10.1016/0304-3940(92)90417-6. [DOI] [PubMed] [Google Scholar]
  44. Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
  45. Sreedharan S. P., Goetzl E. J., Malfroy B. Elevated synovial tissue concentration of the common acute lymphoblastic leukaemia antigen (CALLA)-associated neutral endopeptidase (3.4.24.11) in human chronic arthritis. Immunology. 1990 Sep;71(1):142–144. [PMC free article] [PubMed] [Google Scholar]
  46. Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol. 1986 Jan;136(1):152–156. [PubMed] [Google Scholar]
  47. Ulmer A. J., Mattern T., Feller A. C., Heymann E., Flad H. D. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J Immunol. 1990 Apr;31(4):429–435. doi: 10.1111/j.1365-3083.1990.tb02789.x. [DOI] [PubMed] [Google Scholar]
  48. V Euler U. S., Gaddum J. H. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931 Jun 6;72(1):74–87. doi: 10.1113/jphysiol.1931.sp002763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Walsh D. A., Mapp P. I., Wharton J., Rutherford R. A., Kidd B. L., Revell P. A., Blake D. R., Polak J. M. Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis. 1992 Mar;51(3):313–317. doi: 10.1136/ard.51.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Woolf C. J., Shortland P., Coggeshall R. E. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 1992 Jan 2;355(6355):75–78. doi: 10.1038/355075a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES